CClinicalTrials.gg
CompletedNCT06903104MAEva-proUpdated Dec 26, 2025

Acceptability and Feasibility of a Stress Prevention Program Based on Meditation and Acceptance and Commitment Therapy for Staff at a Cancer Center

An interventional study of Mindfulness closed program and Quality of life evaluation in Employees at a Hospital, sponsored by Institut de Cancérologie de Lorraine. Completed at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-26.

Sponsored by Institut de Cancérologie de Lorraine · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The MAEva program seems to meet the challenges of implementing meditation for cancer care workers. As part of our Quality of Life and Working Conditions initiative, the investigator decided to offer it to staff at our Cancer Center. The MAEva program is delivered in a closed format: participants commit to following, as far as possible, the three sessions of the program - one session per week for 3 weeks. During the sessions, it will be proposed to train meditative practices and three different themes will be addressed (one theme per session): Meditation, Acceptance and Commitment to values.

Before and after the program, participants will complete a quality of life evaluation, a perceived stress scale, and a questionnaire to assess psychological flexibility.

At the end of the program, each participant will be asked to complete a satisfaction questionnaire and a semi-directive interview, by videoconference, or by telephone in the event of digital impossibility with voice recording, to enable a qualitative analysis.

02

Conditions studied

  • Employees at a Hospital

Keywords

  • MAEva program
  • Quality of life
  • Mindfulness
  • Workplace
  • Caregivers
03

In context

Lead sponsor

Institut de Cancérologie de Lorraine is the lead sponsor of 62 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Participant of legal age
  • Willingness to participate in the program - voluntary registration
  • Commitment to attend all 3 program sessions
  • Schedule compatible with participation in the 3 program sessions
  • Participant has understood, signed and dated the consent form
  • Participant affiliated to the social security system

Exclusion criteria

Exclusion Criteria:

  • No desire to participate in the program - non-registration
  • Previous participation in MAEva program
  • No commitment to participate in the 3 program sessions
  • Agenda incompatible with the 3 program sessions
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    MAEva program is delivered in a closed format

    MAEva program is delivered in a closed format. One session per week for 3 weeks.

    Other: Mindfulness closed program · Diagnostic Test: Quality of life evaluation · Diagnostic Test: Perceived Stress Scale · Diagnostic Test: Multidimensional Psychological Flexibility Inventory · Other: satisfaction questionnaire and semi-structured interview

Interventions

  • OtherMindfulness closed program

    MAEva program will be proposed with meditative practices and three different themes will be addressed (one theme per session): Meditation, Acceptance and Commitment to values.

  • Diagnostic testQuality of life evaluation

    The assessment will be carried out at inclusion and after completion of the program.

  • Diagnostic testPerceived Stress Scale

    The assessment will be carried out at inclusion and after completion of the program.

  • Diagnostic testMultidimensional Psychological Flexibility Inventory

    The assessment will be carried out at inclusion and after completion of the program.

  • Othersatisfaction questionnaire and semi-structured interview

    The assessments will be carried out after completion of the program.

06

What researchers measure

Primary outcomes

  1. Evaluate the feasibility and acceptability of the MAEva program among employees at a hospital (CLCC: Centre de Lutte Contre le Cancer or Cancer Center).

    Participation rate of employees at a hospital in the MAEva program and number of sessions attended (number of participants who completed the entire program)

    Time frame: 5 weeks

  2. Evaluate the feasibility and acceptability of the MAEva program among employees at a hospital (CLCC: Centre de Lutte Contre le Cancer or Cancer Center).

    Number of sessions attended (number of participants who completed the entire program)

    Time frame: 5 weeks

Secondary outcomes

  1. Evaluate the initial effectiveness of the MAEva program on the well-being of employees at a hospital.

    Quality of working life assessment (subjective score between 1 and 10 on the Quality of Working Life Scale)

    Time frame: 5 weeks

  2. Evaluate the initial effectiveness of the MAEva program on the well-being of employees at a hospital.

    Stress assessment (Perceived Stress Scale - PSS-10)

    Time frame: 5 weeks

  3. Evaluate the initial effectiveness of the MAEva program on the well-being of employees at a hospital.

    Assessment of psychological flexibility (Multidimensional Inventory of Psychological Flexibility (MPFI-24))

    Time frame: 5 weeks

  4. Evaluate the initial effectiveness of the MAEva program on the well-being of employees at a hospital.

    Assessment of participant satisfaction (subjective score between 1 and 10; open-ended questions (qualitative analysis))

    Time frame: 5 weeks

  5. Evaluate the initial effectiveness of the MAEva program on the well-being of employees at a hospital.

    Assessment of processes at play during the intervention (semi-structured interviews (qualitative analysis))

    Time frame: 5 weeks

07

Study locations

1 site
  • Institut de Cancerologie de Lorraine
    Vandœuvre-lès-Nancy, 54519, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06903104
Lead sponsor
Institut de Cancérologie de Lorraine
Responsible party
Sponsor
First posted
Mar 30, 2025
Start date
Mar 13, 2025
Primary completion
Apr 30, 2025
Completion
Sep 13, 2025
Last update
Dec 26, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion